snmjournals.org14d
Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
Progressive Metastatic Tumors [18F]FDG and [68Ga]Ga-FAPI-04-Directed Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine Neoplasms 68Ga-Fibroblast Activation Protein Inhibitor ...
snmjournals.org16d
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[
Journal of Nuclear Medicine January 2025, jnumed.124.268425; DOI: https://doi.org/10.2967/jnumed.124.268425 ...
C&EN16d
Synthesis and Evaluation of Benzylic
Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, 6200 MD Maastricht, The Netherlands Department of Radiology and Nuclear Medicine, Maastricht University ...
Pharmabiz16d
Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden
Pylclari (INN: Piflufolastat (18F) also known as (18F)-DCFPyL) is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in ...
Yahoo Finance24d
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
[18F]florbetaben has been granted a Fast Track designation for cardiac amyloidosis, which will expedite the development of [18F]florbetaben for this indication [18F]florbetaben previously received ...
BioSpace25d
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
[18F]florbetaben has been granted a Fast Track designation for cardiac amyloidosis, which will expedite the development of [18F]florbetaben for this indication [18F]florbetaben previously received ...